Andrea Pierantozzi
Overview
Explore the profile of Andrea Pierantozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrella A, Fortinguerra F, Cangini A, Pierantozzi A, Trotta F
Front Public Health
. 2023 Oct;
11:1211208.
PMID: 37881343
Background: Many countries use the WHO Essential Medicines List (EML) as a guide for health policy choices to promote the efficient use of healthcare resources or adopt the concept of...
2.
Marano G, Da Cas R, Pierantozzi A, Ippoliti I, Cangini A, Menniti-Ippolito F, et al.
Ann Ist Super Sanita
. 2023 Jun;
59(2):99-100.
PMID: 37337983
No abstract available.
3.
Marano G, Da Cas R, Zito S, Ippoliti I, Fortinguerra F, Pierantozzi A, et al.
Recenti Prog Med
. 2023 Apr;
114(5):268-276.
PMID: 37114608
In 2021, the national expenditure for blood coagulation factors was 541.4 million, growing steadily over the past decade. Hemophilia A is the congenital hemorrhagic disease with the highest drug consumption...
4.
Marano G, Da Cas R, Zito S, Ippoliti I, Cangini A, Pierantozzi A, et al.
Recenti Prog Med
. 2023 Apr;
114(5):258-267.
PMID: 37114607
Therapeutic strategies for the treatment of congenital bleeding disorders. Congenital hemorrhagic diseases (CHDs) are a group of rare disorders caused by quantitative or qualitative deficiency of one or more coagulation...
5.
Marengoni A, Cangini A, Pierantozzi A, Onder G, Da Cas R, Ippoliti I, et al.
Aging Clin Exp Res
. 2023 Mar;
35(4):905.
PMID: 36897557
No abstract available.
6.
Fortinguerra F, Pierantozzi A, Trotta F
Front Public Health
. 2023 Mar;
11:1110435.
PMID: 36875354
Background: Italy has the highest per capita alcohol consumption among European countries. Several pharmacological treatments for alcohol use disorders (AUDs) are currently available in Italy, but no consumption data are...
7.
Perrella A, Fortinguerra F, Pierantozzi A, Capoluongo N, Carannante N, Lo Vecchio A, et al.
Antibiotics (Basel)
. 2023 Jan;
12(1).
PMID: 36671369
Antimicrobial resistance (AMR) represents a major issue in healthcare being correlated to global inappropriate use of antibiotics. The aim of this study was to compare the data on hospital antibiotic...
8.
Ippoliti I, Ancidoni A, Da Cas R, Pierantozzi A, Vanacore N, Trotta F
Neurol Sci
. 2023 Jan;
44(5):1587-1595.
PMID: 36595207
Introduction: Acetylcholinesterase inhibitors (AChEIs) and memantine are currently the only anti-dementia drugs (ADDs) approved for treating Alzheimer's disease (AD) in Italy. This nationwide study aims to characterize dementia drug utilization...
9.
Marengoni A, Cangini A, Pierantozzi A, Onder G, Da Cas R, Ippoliti I, et al.
Aging Clin Exp Res
. 2022 Dec;
35(2):443-453.
PMID: 36469252
Objective: This study aims to analyse the impact of the pandemic on the amount of use and new medication dispensation for chronic diseases in the Italian population aged 65 years...
10.
Zazzara M, Cangini A, Da Cas R, Ippoliti I, Marengoni A, Pierantozzi A, et al.
Front Pharmacol
. 2022 Apr;
13:818875.
PMID: 35370651
Older adults are often affected by multiple chronic conditions and experience geriatric syndromes that may affect the risk/benefit profile of medications. Little is known about the use of such medications...